CGTX
NASDAQ · Pharmaceuticals
Cognition Therapeutics Inc
$1.21
+0.05 (+4.31%)
Open$1.17
Previous Close$1.16
Day High$1.23
Day Low$1.15
52W High$3.83
52W Low$0.22
Volume—
Avg Volume811.7K
Market Cap103.65M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+2,458.7% upside
Current
$1.21
$1.21
Target
$30.96
$30.96
$22.83
$30.96 avg
$36.58
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 14.30M | 12.78M | 15.45M |
| Net Income | 4.19M | 3.83M | 4.28M |
| Profit Margin | 29.3% | 30.0% | 27.7% |
| EBITDA | 6.72M | 5.55M | 6.77M |
| Free Cash Flow | 3.42M | 2.69M | 4.56M |
| Rev Growth | -4.2% | +12.1% | -7.5% |
| Debt/Equity | 0.88 | 0.74 | 0.77 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |